The Effects of VR Interactive Games on Balance and Quality of Life Enhancement for Elderly in the Community

August 2, 2024 updated by: Taipei Medical University

The goal of this clinical trial is to learn about the effectiveness of the incorporating VR interactive games into exercise courses of the elderly in the community.The main questions It aims to answer are: can It improve their balance ability and the quality of life.

Participants will receive a Twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription, While the control group will follow the original iInstructor-led exercise intervention as the course content.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Both groups will undergo three sessions per week, one hour per session, for a total of 12 weeks and 36 sessions of intervention. Before and after competing all sessions, the effectiveness of this intervention will be assessed.

Some physical assessments will be done by all participants such as 2-minute step, right chair sit and reach, left chair sit and reach to compare if any difference between two groups. and participants will do a questionaire to evaluate the psychological and environmental quality of life.

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei, Taiwan
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Aged 65 or above
  2. Capable of communicating in Mandarin or Taiwanese, and willing to participate in interviews or complete questionnaires
  3. Free of mobility impairments

Exclusion Criteria:

  1. Stroke with sequelae of mobility impairments
  2. Parkinson's disease
  3. Motor neurone disease
  4. Severe Cardio-vascular disease
  5. Degenerative joint disease with flare-ups in past three months
  6. With a lower limb joint surgery in past 3 months
  7. Vertigo

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR group
The experimental group received a twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription
Device: VR interactive games
The experimental group received a twelve-week intervention of 36 sessions using VR interactive games in their exercise prescription,
No Intervention: Non-VR group
control group followed the original instructor-led exercise intervention as the course content.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance ability
Time Frame: Physical assessment done 2 weeks before and 2 weeks after 12 weeks courses
The scores of five physical assessments
Physical assessment done 2 weeks before and 2 weeks after 12 weeks courses
Life quality
Time Frame: Questionnaire done 2 weeks before and 2 weeks after 12 weeks courses
The score of questionnaire done by all participants
Questionnaire done 2 weeks before and 2 weeks after 12 weeks courses

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Taipei Medical University

Investigators

  • Study Chair: Chueh-Ho Lin, PhD, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Actual)

June 5, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

June 29, 2023

First Submitted That Met QC Criteria

August 2, 2024

First Posted (Actual)

August 6, 2024

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 2, 2024

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • N202210004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

the datasets generated in this study are available from the corresponding author upon reasonable request.

IPD Sharing Time Frame

the datasets generated in this study are available from the corresponding author upon reasonable request.

IPD Sharing Access Criteria

no criteria

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe